Physician profile
Andrew Eric Andreae
NPI 1689135766
$13,031.00
in general payments reported to CMS, 2019-2025
6 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.38 · 2022: $105 · 2023: $268 · 2024: $3.00 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,000 · Food and Beverage: $3,163 · Travel and Lodging: $1,503 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,000.00 |
| Food and Beverage | $3,162.96 |
| Travel and Lodging | $1,503.36 |
| Education | $161.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,913.43 | 2022-2025 | Emblem Mri S-Icd, General - Therapies, Watchman Flx |
| Medtronic, INC. | $4,437.01 | 2025 | Micra, Azure Xt Dr Mri Surescan, Omniasecure Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $293.69 | 2022-2025 | Lifevest |
| Acutus Medical, INC. | $171.42 | 2021-2023 | |
| Biosense Webster, INC. | $123.05 | 2025 | Carto 3 |
| Cordis US Corp. | $92.40 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Andreae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.